MedTrace Logo

Colchicine as Treatment for People With Hand Osteoarthritis

NCT04601883 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-02-15

No results posted yet for this study

Summary

The study aims to compare oral colchicine 0.5 mg administered two times daily for 12 weeks with placebo as a treatment of hand OA symptoms.

Conditions

  • Osteoarthritis Hand
  • Osteoarthritis Finger

Interventions

DRUG

Colchicine 0.5 MG

The intervention tablets are commercially available Colchicine "Tiofarma"

DRUG

Placebo

Encapsulated placebo tablets. Placebo is identical to the active intervention.

Sponsors & Collaborators

  • Henning Bliddal

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-15
Primary Completion
2022-08-03
Completion
2022-08-03

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04601883 on ClinicalTrials.gov